Rapid Reviews Infectious Diseases
Overdue Last read · last published · next check
Last read 14 hours ago, longer than this feed's 4 hours schedule.
Despite certain limitations, reviewers considered the study an elegant proof-of-concept that bacteriophage infection can serve as a simple, scalable platform for identifying antiviral human ISGs and exploring their function.
Despite certain limitations, reviewers considered the study an elegant proof-of-concept that bacteriophage infection can serve as a simple, scalable platform for identifying antiviral human ISGs and exploring their function.
Despite certain limitations, reviewers considered the study an elegant proof-of-concept that bacteriophage infection can serve as a simple, scalable platform for identifying antiviral human ISGs and exploring their function.
Reviewers: J MacMicking (HHMI, Yale University) & S Silverman (Yale University) & K V Narvaez (Yale University) | 📗📗📗📗◻️ • T Nagy (University of Colorado Boulder) | 📗📗📗📗◻️ • J Pogliano (UC San Diego) | 📗📗📗📗◻️
Reviewers support the core discovery but recommend additional experiments and more restrained framing before the broader mechanistic and diagnostic conclusions are considered fully established.
Reviewers support the core discovery but recommend additional experiments and more restrained framing before the broader mechanistic and diagnostic conclusions are considered fully established.
Reviewers support the core discovery but recommend additional experiments and more restrained framing before the broader mechanistic and diagnostic conclusions are considered fully established.
Reviewers: K Jiang (Princeton University) | 📗📗📗📗◻️ • H Li (Van Andel Institute) | 📘📘📘📘📘 • H Zhang & J Yang (Tianjin Medical University) | 📘📘📘📘📘
Reviewers agreed that the study identifies a promising antibiotic-potentiating strategy, but emphasized that stronger validation and disease-relevant infection models are needed before conclusions can be fully supported.
Reviewers agreed that the study identifies a promising antibiotic-potentiating strategy, but emphasized that stronger validation and disease-relevant infection models are needed before conclusions can be fully supported.
